GCM
ACAD icon

Graham Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Graham Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,426
Closed -$436K – 1193
2025
Q3 		$436K Buy
20,426
+3,371
+20% +$79.7K 0.02% 669
2025
Q2 		$368K Sell
17,055
-81,631
-83% -$1.52M 0.01% 925
2025
Q1 		$1.64M Buy
98,686
+36,909
+60% +$671K 0.05% 398
2024
Q4 		$1.13M Buy
+61,777
New +$997K 0.04% 456
2024
Q2 		– Sell
-23,238
Closed -$430K – 1007
2024
Q1 		$430K Buy
23,238
+13,908
+149% +$345K 0.01% 669
2023
Q4 		$292K Buy
+9,330
New +$223K 0.01% 738
2022
Q2 		– Sell
-17,374
Closed -$420K – 974
2022
Q1 		$420K Buy
+17,374
New +$420K 0.02% 616

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return